Abstract

Elevated circulating total homocysteine (tHcy) concentrations (hyperhomocysteinemia) have been regarded as an independent risk factor for cardiovascular disease (CVD). However, several large clinical trials to correct hyperhomocysteinemia using B-vitamin supplements (particularly folic acid) have largely failed to reduce the risk of CVD. There is no doubt that a large segment of patients with CVD have hyperhomocysteinemia; therefore, it is reasonable to postulate that circulating tHcy concentrations are in part a surrogate marker for another, yet-to-be-identified risk factor(s) for CVD. We found that iron catalyzes the formation of Hcy from methionine, S-adenosylhomocysteine and cystathionine. Based on these findings, we propose that an elevated amount of non-protein-bound iron (free Fe) increases circulating tHcy. Free Fe catalyzes the formation of oxygen free radicals, and oxidized low-density lipoprotein is a well-established risk factor for vascular damage. In this review, we discuss our findings on iron-catalyzed formation of Hcy from thioethers as well as recent findings by other investigators on this issue. Collectively, these support our hypothesis that circulating tHcy is in part a surrogate marker for free Fe, which is one of the independent risk factors for CVD.

Highlights

  • Homocysteine (Hcy) is exclusively formed from methionine (Met) through the transmethylation pathway [1]

  • We summarize results in the literature together with our investigations, which possibly indicate that circulating total Hcy (tHcy) is in part a surrogate for non-protein-bound iron, which is considered to be one of the independent risk factors for cardiovascular disease (CVD) [6]

  • Ubbink et al [19] later reported that the mean plasma tHcy increased by about 190% in EDTA-containing whole blood stored at room temperature for 24 h, whereas the increase was only 20% using sodium fluoride (NaF)-containing whole blood, and no such increase was observed when whole blood was stored at 4 °C

Read more

Summary

Introduction

Homocysteine (Hcy) is exclusively formed from methionine (Met) through the transmethylation pathway [1]. Nutrients 2015, 7 extremely high circulating total Hcy (tHcy) concentrations (often >500 μmol/L) and suggested that it is detrimental to the integrity of the vascular wall This association received little attention until 1991, when Clarke et al [3] reported that hyperhomocysteinemia is an independent risk factor of cardiovascular disease (CVD); the “Hcy-CVD” hypothesis was born. These findings indicated that lowering tHcy is not effective in reducing the CVD-risk; circulating tHcy may be a surrogate marker of another, yet-to-be-identified, risk factor(s) for CVD. Iron catalyzes the formation of oxygen free radicals, especially when chelated by EDTA [7], and Sullivan [8] postulated that excess iron leads to atherosclerosis through oxygen free radical oxidation of LDL-C This hypothesis is controversial, it is supported by epidemiological data [9]. We believe that Met (or Met as a part of protein), S-adenosylhomocysteine and cystathionine are constantly exposed to free iron at acidic pHs during iron exchange, leading to Hcy formation

Iron-Hcy Interaction
Plasma tHcy and Anticoagulants Used for Blood Collection
Recent Studies on Iron and Hcy in Humans
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.